(Dimethylamino)acetaldehyde Diethyl Acetal CAS 3616-56-6 Mimọ>99.0% (GC) Afatinib Dimaleate Agbedemeji Factory
Ruifu Kemikali Ipese Intermediates of Afatinib
Afatinib CAS 439081-18-2
Afatinib Dimaleate CAS 850140-73-7
(S)-(+)-3-Hydroxytetrahydrofuran CAS 86087-23-2
(Dimethylamino) acetaldehyde Diethyl Acetal CAS 3616-56-6
trans-4-Dimethylaminocrotonic Acid Hydrochloride CAS 848133-35-7
Diethylphosphonoacetic Acid CAS 3095-95-2
7-Fluoro-6-Nitroquinazolin-4 (1H) -ọkan CAS 162012-69-3
7-Chloro-6-Nitro-4-Hydroxyquinazoline CAS 53449-14-2
N-(3-Chloro-4-Fluorophenyl)-7-Fluoro-6-Nitroquinazolin-4-Amine CAS 162012-67-1
(S) -N4- (3-Chloro-4-Fluorophenyl) -7- ((Tetrahydrofuran-3-yl) oxy) quinazoline-4,6-DiamineCAS 314771-76-1
(S)-N- (3-Chloro-4-Fluorophenyl)-6-Nitro-7-((Tetrahydrofuran-3-yl) oxy) quinazolin-4-AmineCAS 314771-88-5
Orukọ Kemikali | (Dimethylamino) acetaldehyde Diethyl Acetal |
Awọn itumọ ọrọ sisọ | 2,2-Diethoxy-N, N-Dimethylethylamine;N- (2,2-Diethoxyethyl) dimethylamine;2,2-Diethoxy-N, N-Dimethylethan-1-Amine |
Nọmba CAS | 3616-56-6 |
NỌMBA CAT | RF-PI2031 |
Iṣura Ipo | Ninu Iṣura, Iwọn iṣelọpọ Ti o to Awọn Toonu |
Ilana molikula | C8H19NO2 |
Òṣuwọn Molikula | 161.25 |
Ifamọ | Ọrinrin Sensitive |
Ojuami farabale | 60℃/5 mmHg |
Oju filaṣi | 45 ℃ |
Brand | Ruifu Kemikali |
Nkan | Awọn pato |
Ifarahan | Liquid Ko Awọ |
Mimọ / Analysis Ọna | > 99.0% (GC) |
Atọka Refractive N20/D | 1.410 ~ 1.414 |
Walẹ Kan pato (20/20℃) | 0.865 ~ 0.870 |
Proton NMR julọ.Oniranran | Ni ibamu si Eto |
Lapapọ Awọn Aimọ | <1.00% |
Awọn irin Heavy (gẹgẹbi Pb) | ≤20ppm |
Igbeyewo Standard | Standard Enterprise |
Lilo | Awọn agbedemeji elegbogi;Afatinib Dimaleate;Sumatriptan |
Package: Igo Fluorinated, 25kg/Drum, tabi gẹgẹ bi ibeere alabara
Ipò Ìpamọ́:Fipamọ sinu awọn apoti ti a fi edidi ni itura ati ibi gbigbẹ;Dabobo lati ina ati ọrinrin
(Dimethylamino) acetaldehyde Diethyl Acetal (CAS: 3616-56-6) ni a lo bi awọn agbedemeji elegbogi.(Dimethylamino) acetaldehyde Diethyl Acetal le ṣee lo ni iṣelọpọ ti Afatinib Dimaleate (CAS: 850140-73-7), Sumatriptan (CAS: 103628-46-2).Afatinib (orukọ iṣowo Gilotrif ni AMẸRIKA ati Giotrif ni Yuroopu, tẹlẹ Tomtovok ati Tovok) jẹ oogun ti a fọwọsi ni Amẹrika, Yuroopu, Taiwan, Mexico, Chile ati Japan ati awọn orilẹ-ede miiran fun itọju laini akọkọ ti awọn alaisan ti o ni iyasọtọ orisi ti metastatic (EGFR iyipada rere) ti kii-kekere cell ẹdọfóró carcinoma (NSCLC), ni idagbasoke nipasẹ Boehringer Ingelheim.Afatinib n ṣe bi oludanukọ covalent ti ko le yipada ti olugba tyrosine kinases epidermal growth factor receptor (EGFR) ati erbB-2 (HER2).Sumatriptan ni akọkọ triptan ti a fọwọsi (1991) fun itọju akàn ti awọn efori migraine.O ni bioavailability ni isalẹ laarin gbogbo awọn triptans nitori lowlipophilicity rẹ.Wiwa ti ọpọlọpọ awọn ọna iwọn lilo oriṣiriṣi (ie, tabulẹti oral, abẹrẹ SC, ilana ifun imu, ati suppository) ngbanilaaye irọrun ti tailoringtherapy si awọn iwulo ti awọn alaisan kọọkan, nitorinaa ṣiṣe awọn sumatriptans oogun ti o wulo pupọ fun itọju nla ti migraine. efori.Sumatriptan tun ni iyara pupọ ti iṣe nipasẹ abẹrẹ SC tabi iṣakoso imu sokiri imu.